THERAGENICS CORP
TGX
TGX was delisted on the 29th of October, 2013.
0 hedge funds and large institutions have $0 invested in THERAGENICS CORP in 2013 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 41 closing their positions.
100% less funds holding
Funds holding: 41 → 0 (-41)
100% less capital invested
Capital invested by funds: $32.3M → $0 (-$32.3M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 41
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.73M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$5.33M |
| 3 |
Renaissance Technologies
New York
|
-$3.79M |
| 4 |
LIM
Longfellow Investment Management
Boston,
Massachusetts
|
-$3.18M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$2.85M |
TGX Hedge Fund Activity: Q4 2013 in Review
0 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in THERAGENICS CORP (TGX) for Q4 2013, worth a combined $0 — down 100% from $32.3M a quarter earlier.
Sellers outnumbered buyers: 41 funds closed out of TGX and 0 opened new positions — a net loss of 41 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Fidelity Investments, exiting entirely with an estimated $6.73M sold.
- 0 institutional investors held THERAGENICS CORP (TGX) as of Q4 2013, down from 41 in Q3 2013.
- Funds reported $0 of THERAGENICS CORP stock for Q4 2013, down 100% quarter-over-quarter.
- 0 funds opened new THERAGENICS CORP positions in Q4 2013 and 41 closed out, a net change of -41 holders.
- The largest THERAGENICS CORP seller in Q4 2013 was Fidelity Investments, an estimated $6.73M sold.
Based on aggregated 13F filings for Q4 2013.